Top cited articles
Time to first decision:
1 days*
Time to first decision with review:
44 days*
Acceptance to publication:
26 days*
Impact Factor:
9.8
Total content views:
376,933
Total Altmetric mentions:
11,909
Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane
Rapid reviews methods series: Guidance on literature search
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression
Shared decision-making as a method of care
Using individual participant data to improve network meta-analysis projects
Patient-reported outcome measures (PROMs) as proof of treatment efficacy
Rapid reviews methods series: Guidance on team considerations, study selection, data extraction and risk of bias assessment
Transparency of COVID-19 vaccine trials: decisions without data
Theory and practice of Bayesian and frequentist frameworks for network meta-analysis
Replacing PICO in non-interventional studies
Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review
Adapt or die: how the pandemic made the shift from EBM to EBM plus more urgent
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
The limits of shared decision making
Component network meta-analysis in a nutshell
Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews
How to interpret studies using Mendelian randomisation
Making care fit manifesto
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies
Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review